Vicarious Surgical (RBOT) Preferred Stock Liabilities (2020 - 2021)
Vicarious Surgical (RBOT) posted quarterly Preferred Stock Liabilities of $275.6 million for Q2 2021, down 7.09% quarter-over-quarter from $296.6 million in Q1 2021.
Vicarious Surgical (RBOT) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
Vicarious Surgical (RBOT) has reported Preferred Stock Liabilities for 2 consecutive years, with $275.6 million the latest figure, recorded in Q2 2021.
- In Q2 2021, Preferred Stock Liabilities changed N/A year-over-year to $275.6 million; the TTM figure through Jun 2021 stood at $275.6 million (changed N/A YoY), while the FY2020 annual figure was $299.8 million, changed N/A from the prior year.
- Preferred Stock Liabilities eased to $275.6 million in Q2 2021 per RBOT's latest filing, from $296.6 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $329.3 million in Q3 2020 and bottomed at $275.6 million in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | - |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | - |
| 10 | Vicarious Surgical | 196,495.36 | -14.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 275.59 Mn |
| Mar 31, 2021 | 296.62 Mn |
| Dec 31, 2020 | 299.80 Mn |
| Sep 30, 2020 | 329.26 Mn |